Nurse Practitioner, Family · Oklahoma City, OK
NPI
1235728163
Since 2021
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
13029 Burlingame Ave
Oklahoma City, OK, 73120
Phone (405) 823-0506
Groups this clinician bills Medicare through
Medicare paid, 2024
$58K
319 services
Medicare patients, 2024
76
Average age 60
Drug cost, 2024
$281K
528 prescriptions
Company payments, 2025
$323
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kathryn A Schneider was code 90961 (esrd related services (not dialysis)), 148 times for 55 patients. In total Kathryn A Schneider billed 319 services in 5 codes, and Medicare paid $58K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 90961 ESRD Related Services (not dialysis) | Office | 148 | 55 | $182.35 | $27K |
| 90960 ESRD Related Services (not dialysis) | Office | 108 | 49 | $220.69 | $24K |
| 90962 ESRD Related Services (not dialysis) | Office | 34 | 26 | $126.74 | $4,309 |
By year: 2022 $58K for 290 services; 2023 $51K for 261 services; 2024 $58K for 319 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kathryn A Schneider prescribed most often to Medicare patients was Veltassa (Patiromer Calcium Sorbitex), with 42 prescriptions and refills. In total Kathryn A Schneider wrote 528 Medicare prescriptions that cost $281K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Veltassa Patiromer Calcium Sorbitex | 42 | 56 | Under 11 | $41K |
| Nifedipine Er Nifedipine | 36 | 78 | 12 | $884 |
| Clonidine Hcl Generic | 33 | 62 | 13 | $206 |
| Amlodipine Besylate Generic | 32 | 54 | 13 | $154 |
| Velphoro Sucroferric Oxyhydroxide | 30 | 32 | Under 11 | $76K |
| Lanthanum Carbonate Generic | 24 | 31 | Under 11 | $29K |
| Hydralazine Hcl Generic | 23 | 57 | 12 | $367 |
| Sevelamer Carbonate Generic | 22 | 38 | Under 11 | $5,740 |
| Calcium Acetate Generic | 21 | 31 | Under 11 | $2,642 |
| Fosrenol Lanthanum Carbonate | 20 | 22 | Under 11 | $31K |
| Carvedilol Generic | 18 | 43 | Under 11 | $168 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 15 | 15 | Under 11 | $296 |
| Torsemide Generic | 14 | 37 | Under 11 | $333 |
| Eliquis Apixaban | 12 | 18 | Under 11 | $10K |
| Xphozah Tenapanor Hcl | 12 | 24 | Under 11 | $70K |
Brand drugs: 134 claims; generic drugs: 394 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kathryn A Schneider $323 ($323 in general payments such as food, travel and fees) from 2 companies. The largest payer was Ardelyx, Inc. with $215.
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. ARDX | 2 | $215 |
| Fresenius USA Marketing, Inc. | 6 | $108 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.